Mont-saint-guibert
Walloon Brabant
Novadip
is a Belgium-based biopharmaceutical company that researches and commercializes tissue regeneration therapies for the treatment of cancer and orthopedic conditions... Read moreNovadip
is a Belgium-based biopharmaceutical company that researches and commercializes tissue regeneration therapies for the treatment of cancer and orthopedic conditions... Read moreNews
Feb 20, 2025
Clinical Trials Arena
Novadip: Novadip's bone graft material unifies fractures in 100% of patients
Jan 28, 2025
Pharmafile
Novadip: Results from Novadip phase 1b/2a trial reveal 88% efficacy
Oct 17, 2024
Orthopedic Design & Technology
Novadip: Novadip Reports Interim Results from NVDX3 Trial
Dec 06, 2023
Post Online Media
Novadip: Novadip Biosciences announced significant clinical milestones for both of its clinical stage programs
Aug 15, 2023
Orthopedic Design & Technology
Novadip: Novadip's Tissue Regeneration Product Used in First Pediatric Cases
May 17, 2023
FinanzNachrichten
Novadip: Novadip Biosciences SA Announces First Pediatric Patient with Congenital Pseudoarthrosis of the Tibia Undergoes Implantation with NVD-003, an Autologous Tissue Regeneration Product, in Phase 1b/2a US/EU Clinical Trial
Apr 18, 2023
Orthopedic Design & Technology
Novadip: Judy Ashworth Named Chief Medical Officer at Novadip Biosciences
Apr 13, 2023
Orthopedic Design & Technology
Novadip: Positive Results Achieved With Novadip Biosciences' Tissue Engineered Product
Dec 13, 2022
Orthopedic Design & Technology
Novadip: Novadip Biosciences Shares Positive Results from Phase 1/2 Clinical Trial Evaluating NVD-003
Oct 28, 2021
BioSpace
Novadip: Novadip Biosciences announces EUR 19 million Series B financing backed by international investors
